Cailing Wan

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Co-Production of KPC-2 and NDM-5 in a Carbapenem-Resistant Klebsiella Pneumoniae Clinical Isolate: Genetic Insights and Risks.

Co-Production of KPC-2 and NDM-5 in a Carbapenem-Resistant Klebsiella Pneumoniae Clinical Isolate: Genetic Insights and Risks.

Journal: Infection and drug resistance

Published: March 19, 2025

Sub-inhibitory concentrations of tigecycline could attenuate the virulence of Staphylococcus aureus by inhibiting the product of α-toxin.

Sub-inhibitory concentrations of tigecycline could attenuate the virulence of Staphylococcus aureus by inhibiting the product of α-toxin.

Journal: Microbiology spectrum

Published: March 19, 2025

Emergence and dissemination of multidrug-resistant Klebsiella pneumoniae harboring the novel tmexCD-toprJ RND efflux pump operon.

Emergence and dissemination of multidrug-resistant Klebsiella pneumoniae harboring the novel tmexCD-toprJ RND efflux pump operon.

Journal: Frontiers in cellular and infection microbiology

Published: February 26, 2025

Dissemination of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae ST792 in Southern China.

Dissemination of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae ST792 in Southern China.

Journal: Frontiers in microbiology

Published: February 21, 2025

The roles of cell wall inhibition responsive protein CwrA in the pathogenicity of Staphylococcus aureus.

The roles of cell wall inhibition responsive protein CwrA in the pathogenicity of Staphylococcus aureus.

Journal: Virulence

Published: October 03, 2024

Insights into small-molecule compound CY-158-11 antibacterial activity against Staphylococcus aureus.

Insights into small-molecule compound CY-158-11 antibacterial activity against Staphylococcus aureus.

Journal: mSphere

Published: September 23, 2024

Characterization of a novel KPC-2 variant, KPC-228, conferring resistance to ceftazidime-avibactam in an ST11-KL64 hypervirulent Klebsiella pneumoniae.

Characterization of a novel KPC-2 variant, KPC-228, conferring resistance to ceftazidime-avibactam in an ST11-KL64 hypervirulent Klebsiella pneumoniae.

Journal: International journal of antimicrobial agents

Published: September 10, 2024

Phenotypic and genomic analysis of the hypervirulent methicillin-resistant Staphylococcus aureus ST630 clone in China.

Phenotypic and genomic analysis of the hypervirulent methicillin-resistant Staphylococcus aureus ST630 clone in China.

Journal: mSystems

Published: August 19, 2024

Identification and validation of diagnostic biomarkers and immune cell abundance characteristics in Staphylococcus aureus bloodstream infection by integrative bioinformatics analysis.

Identification and validation of diagnostic biomarkers and immune cell abundance characteristics in Staphylococcus aureus bloodstream infection by integrative bioinformatics analysis.

Journal: Frontiers in immunology

Published: June 18, 2024

Characteristic of KPC-12, a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in the Carbapenem-Resistant Klebsiella pneumoniae ST11-KL47 Clone Background.

Characteristic of KPC-12, a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in the Carbapenem-Resistant Klebsiella pneumoniae ST11-KL47 Clone Background.

Journal: Infection and drug resistance

Published: April 07, 2024

Novel small-molecule compound YH7 inhibits the biofilm formation of Staphylococcus aureus in a sarX-dependent manner.

Novel small-molecule compound YH7 inhibits the biofilm formation of Staphylococcus aureus in a sarX-dependent manner.

Journal: mSphere

Published: January 03, 2024

Showing 1-11 of 11

Last Updated: 09/26/2026